Drug Research
GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to a Diagnostic Assay for Non-Alcoholic SteatoHepatitis
LabCorp, a leading global life sciences company, and GENFIT , a biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting...
News
FDA grants fast track designation to ImmusanT’s vaccine for celiac disease
Clinical-stage company ImmusanT’s therapeutic vaccine candidate Nexvax2 has been granted fast track designation by the US FDA. ImmusanT uses its trademarked...
Drug Research
Propanc Biopharma Commences Drug Discovery Research Collaboration
Propanc Biopharma, Inc , a clinical stage biopharmaceutical company focused on development of new and proprietary treatments for cancer patients suffering from solid tumors...
Drug Research
Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv University
Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP molecules for the treatment...
Industry Reports
Bristol-Myers Squibb to acquire Celgene in $74bn deal
Bristol-Myers Squibb Company and Celgene Corporation announced that they have entered into a definitive merger agreement under which Bristol-Myers Squibb will acquire Celgene in...
News
Canadian companies complete handover of drugs rights
Nuvo Pharmaceuticals has acquired the rights covering more than 20 drugs from fellow Canadian company Aralez Pharmaceuticals. With the deal, announced...
Press Releases
Eisai’s New Drug Application for Perampanel Designated for Priority Review by China National Medical Products Administration
Eisai Co., Ltd. announced that its in-house discovered and developed antiepileptic drug (AED) perampanel , for which a NDA was submitted for review as...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read